2.5 mg retatrutide results vs tirzepatide dosage chart: complete comparison guide for every dose VisualAbstract: Retatrutide reduces body weight

Foundayo is available for delivery and does not require refrigeration - a meaningful practical advantage over injectable GLP-1 medications

In the Phase 2 trial, retatrutide 12 mg weekly produced mean weight loss of 24.2% at 48 weeks, with the highest-dose group achieving 28.7% at the same timepoint in the TRIUMPH-4 Phase 3 trial

In today's post, we'll break down what we doand don'tknow about these medications as of August 2024

However, it is vital to note that the compound remains investigational and is not yet broadly approved for commercial pharmaceutical use

Companies that sell these drugs are able to skirt federal regulations by writing all over their website that the compounds are not for human consumption and are instead meant for research lab purposes advice that users are pretty clearly not following